Evidence map›Paper›PMID 21786026›Full record

ArticleImmunologic research2011

Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.

Vladimir Petrušić, Irena Zivković, Marijana Stojanović, Ivana Stojićević, Emilija Marinković, Aleksandra Inić-Kanada, Ljiljana Dimitijević

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM.Journal of the American Society for Mass Spectrometry · 2016
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vladimir PetrušićDepartment of Research and Development, Institute of Virology, Vaccines and Sera-Torlak, Vojvode Stepe 458, 11221 Belgrade, Serbia. vzpetrusic@gmail.com
Irena Zivković
Marijana Stojanović
Ivana Stojićević
Emilija Marinković
Aleksandra Inić-Kanada
Ljiljana Dimitijević
Institute of Virology, Vaccines and Sera “Torlak” · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural antibodies (NAbs) are present in circulation even before the exposure to antigen and they exert various biological functions. They are polyreactive and mainly represented by immunoglobulin M (IgM), which is the first antibody produced in an ongoing immune response to infection and/or immunization. IgM is always secreted as a polymer with predominant pentameric structure, although other polymeric forms such as hexamer can be also formed. The biological functions of hexameric IgM are still not known and it is proposed that its existence as a NAb could be deleterious. However, the nature of IgM hexamers has not been investigated yet. In this paper, we have tested the expression of natural idiotope and antigenic specificities of pentameric and hexameric IgM polymers originating from sera of patients with Waldenström's macroglobulinemia, as well as patients suffering from recurrent urinary bacterial infections. We demonstrate that although pentameric IgM polymers can exist as natural and immune antibodies, IgM hexamers are exclusively immune and do not exist as NAbs.

Indexed as

Antibody SpecificityBacteriuriaFemaleHumansImmunoglobulin J-ChainsImmunoglobulin MMaleProtein MultimerizationWaldenstrom MacroglobulinemiaImmunoglobulin J-ChainsImmunoglobulin M

Identifiers

PMID21786026
OpenAlexW2090336372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.